Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension
Clinical trial NCT01873885 · COMPLETED
Trial details
- NCT number
- NCT01873885
- Sponsor
- PhaseBio Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.